Why middle age muscle health measurement matters & and how body composition analysers can help

Published on 18 Mar 2026

Why middle age muscle health measurement matters & and how body composition analysers can help

Sarcopenia has historically been viewed as an elderly care concern. However, the latest guidelines from the Asian Working Group for Sarcopenia (AWGS) has highlighted the need for a different approach.

Rather than focusing solely on older adults, the emphasis should be on promoting lifelong muscle health, starting in middle age and with the right equipment, i.e. a body composition analyser.

We understand the importance of accurate measurement in preventative healthcare. The updated Asia-specific Consensus from the AWGS reinforces a simple, but powerful message - early detection can lead to better outcomes.

What is sarcopenia?

Sarcopenia is defined as being the age-related loss of skeletal muscle mass and muscle function. It’s associated with increased risk of falls, frailty, functional decline and chronic health conditions. Traditionally, diagnosis often occurs once mobility issues are already present.

Interestingly, the latest Consensus guidance shifts the focus to earlier identification, which is underpinned by detecting low muscle mass and reduced strength before serious physical limitations develop.

Two-step diagnosis

One of the most significant changes highlighted by the AWGS standards is a simplified diagnostic pathway that comprises the following two steps:

1. Low muscle mass (the quantity of muscle) and;
2. Low muscle strength (the quality of muscle).

This streamlined, two-step approach is aimed at making the diagnostic process more practical and accessible. Rather than waiting for advanced physical decline, clinicians are encouraged to measure muscle mass and strength proactively, identifying risks earlier and intervening sooner.

Why 50 is now a key milestone

Another major development is the formal inclusion of middle-aged adults. The AWGS has introduced defined cut-off values for individuals aged 50 to 64, which is a critical change.

Muscle mass and strength begin to decline gradually from midlife, and building muscle becomes progressively more challenging with age. By establishing diagnostic thresholds for this age group, healthcare professionals can now identify risk factors in patients in their 50s or early 60s, providing a valuable opportunity to intervene before substantial loss develops.

This preventative approach aligns closely with modern healthcare priorities: early detection, data-driven monitoring and long-term functional wellbeing.

Measuring muscle mass: The role of BIA 

Accurate measurement is essential for effective diagnosis. Bioelectrical Impedance Analysis (BIA) is a recognised and widely-used method for assessing body composition, including skeletal muscle mass.

Compared to dual-energy X-ray absorptiometry (DXA), BIA is faster, non-invasive and does not expose patients to radiation. This makes it particularly suitable for use in clinics, community health programmes and general practice settings.

A key metric outlined in the latest AWGS guidelines is the Appendicular Skeletal Muscle Index (ASMI). ASMI standardises arm and leg muscle mass relative to height, providing a consistent and clinically relevant measure of sarcopenia risk.

Modern body composition scales, like our MA801 Professional Body Composition Analyser, are capable of calculating and displaying ASMI directly, allowing healthcare professionals to quickly interpret results in line with AWGS criteria.

Assessing muscle strength: Grip strength counts

While muscle mass reflects quantity, muscle strength reflects functional quality. Grip strength has long been recognised as a reliable indicator of overall muscle strength and physical performance.

The latest advanced body composition analysers, such as the MA801, incorporate grip strength estimation functions. They can provide a helpful preliminary indicator, particularly in environments where grip strength testing isn’t routinely performed. A downward trend in estimated grip strength may signal the need for further functional testing.

Turning data into prevention

The updated guidelines send a clear message, start measuring muscle health sooner.

By combining skeletal muscle measurement through BIA with objective grip strength testing, healthcare providers can develop a comprehensive picture of muscle quantity and functional capability. This data empowers clinicians to recommend targeted exercise, resistance training, nutritional support and lifestyle interventions before muscle decline starts to significantly impact quality of life.

For organisations investing in preventative health programmes, reliable and accurate equipment is central to delivering meaningful outcomes. Consistent readings, ease of use, and clinical-grade precision can make sure that decisions are based on dependable data.

A new era for muscle health monitoring

The AWGS update represents more than a technical revision. It signals a broader cultural shift in how we think about ageing, strength and preventative healthcare.

Here at Marsden Weighing Solutions, we support healthcare professionals with precision measurement solutions that enable the accurate assessment of body composition and muscle strength. By adopting proactive monitoring strategies aligned with the latest AWGS and wider industry insight, practitioners can help people maintain strength, independence, and functional wellbeing for years to come.

Designed to accurately analyse weight, body fat and much more, our range of body composition scales are used in a wide range of settings, including hospitals, doctors surgeries, gyms and sports clubs.

For further information or to discuss your body composition scale requirements with us, complete the short form on this page or email us at sales@marsdengroup.co.uk